Lise L Gluud

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi Systematic review: tranexamic acid for upper gastrointestinal bleeding
    L L Gluud
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Aliment Pharmacol Ther 27:752-8. 2008
  2. ncbi Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Lise Lotte Gluud
    Department of Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Metab Brain Dis 28:221-5. 2013
  3. ncbi Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults
    Lise Lotte Gluud
    Department of Internal Medicine, Gentofte University Hospital, Hellerup, Denmark
    Cochrane Database Syst Rev 8:CD004544. 2012
  4. ncbi Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices
    L L Gluud
    Department of Internal Medicine, Copenhagen University Hospital, Gentofte, Denmark
    Aliment Pharmacol Ther 32:859-71. 2010
  5. ncbi Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
    Lise L Gluud
    Department of Internal Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Hepatology 51:576-84. 2010
  6. ncbi Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus
    Lise Lotte Gluud
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen 2200, Denmark
    Am J Gastroenterol 104:2335-41; quiz 2342. 2009
  7. ncbi Meta-analyses on viral hepatitis
    Lise L Gluud
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Infect Dis Clin North Am 23:315-30. 2009
  8. ncbi Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials
    Jesper Brok
    The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Denmark
    Am J Gastroenterol 101:842-7. 2006
  9. ncbi Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials
    Jesper Brok
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Arch Intern Med 165:2206-12. 2005
  10. ncbi Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials
    Lise L Gluud
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Am J Gastroenterol 102:2842-8; quiz 2841, 2849. 2007

Detail Information

Publications12

  1. ncbi Systematic review: tranexamic acid for upper gastrointestinal bleeding
    L L Gluud
    Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Aliment Pharmacol Ther 27:752-8. 2008
    ..Tranexamic acid may reduce upper gastrointestinal bleeding and stabilize patients before endoscopic treatments...
  2. ncbi Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Lise Lotte Gluud
    Department of Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Metab Brain Dis 28:221-5. 2013
    ..Additional evidence is needed to evaluate the effect of combining all three interventions...
  3. ncbi Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults
    Lise Lotte Gluud
    Department of Internal Medicine, Gentofte University Hospital, Hellerup, Denmark
    Cochrane Database Syst Rev 8:CD004544. 2012
    ..Trials on banding ligation versus non-selective beta-blockers for patients with oesophageal varices and no history of bleeding have reached equivocal results...
  4. ncbi Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices
    L L Gluud
    Department of Internal Medicine, Copenhagen University Hospital, Gentofte, Denmark
    Aliment Pharmacol Ther 32:859-71. 2010
    ..The evidence concerning the use of isosorbide-mononitrate (IsMn) for oesophageal varices is equivocal...
  5. ncbi Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
    Lise L Gluud
    Department of Internal Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark
    Hepatology 51:576-84. 2010
    ..Considering the small number of patients included, the evidence does not allow for treatment recommendations regarding type 2 HRS or any of the remaining treatment comparisons assessed...
  6. ncbi Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus
    Lise Lotte Gluud
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen 2200, Denmark
    Am J Gastroenterol 104:2335-41; quiz 2342. 2009
    ..The aim of this study was to assess the effects of peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus (HIV)...
  7. ncbi Meta-analyses on viral hepatitis
    Lise L Gluud
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Infect Dis Clin North Am 23:315-30. 2009
    ..Additional research including large, randomized trials is necessary to clarify the true intervention effects...
  8. ncbi Ribavirin monotherapy for chronic hepatitis C infection: a Cochrane Hepato-Biliary Group systematic review and meta-analysis of randomized trials
    Jesper Brok
    The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Copenhagen University Hospital, Denmark
    Am J Gastroenterol 101:842-7. 2006
    ..Patients intolerant to interferon should not continue treatment with ribavirin alone outside randomized trials...
  9. ncbi Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials
    Jesper Brok
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Arch Intern Med 165:2206-12. 2005
    ..However, combination therapy is associated with increased risk for adverse events...
  10. ncbi Banding ligation versus beta-blockers as primary prophylaxis in esophageal varices: systematic review of randomized trials
    Lise L Gluud
    Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Am J Gastroenterol 102:2842-8; quiz 2841, 2849. 2007
    ..To compare banding ligation versus beta-blockers as primary prophylaxis in patients with esophageal varices and no previous bleeding...
  11. ncbi Agreement between Cochrane Neonatal Group reviews and clinical guidelines for newborns at a Copenhagen University Hospital - a cross-sectional study
    Jesper Brok
    The Cochrane Hepato Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, H S Rigshospitalet, Denmark
    Acta Paediatr 96:39-43. 2007
    ....
  12. ncbi The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials
    Lise L Gluud
    The Cochrane Hepato-Biliary Group, The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen, Denmark
    Am J Gastroenterol 100:2431-5. 2005
    ..However, even trials in high impact journals may be small or may have inadequate quality. Critical appraisal of individual trials is always necessary, irrespective of the place of publication...